Skip to main content
. 2024 May 31;10:267. doi: 10.1038/s41420-024-02039-7

Fig. 5. Role of peroxiredoxin I and II in cervical cancer patient survival.

Fig. 5

A Evaluation of PRDXs family expression in cervical cancer patients utilizing UALCAN database (https://ualcan.path.uab.edu/). B Prognostic survival analysis of PRDX1 and PRDX2 in cervical cancer using UALCAN. C Assessment of PRDX1 and PRDX2 expression across different stages of cervical cancer via UALCAN. D Comparative study of PRDX1 and PRDX2 expression in normal and cervical cancer tissues using Human Protein Atlas (https://www.proteinatlas.org/). Significance indicated by *P < 0.05; **P < 0.01; ***P < 0.001.